The role of NF-κB in the pathogenesis of heart failure and endotoxemia

Drugs of the Future

Volumn 29, Issue 7, 2004, Pages 733-739

  Matsumori, Akira ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 (3 DIMETHYLAMINOPROPIONYL)FORSKOLIN; ACETYLSALICYLIC ACID; AMRINONE; ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; ANTIOXIDANT; CANDESARTAN; CYCLOSPORIN; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHODIESTERASE III; PIMOBENDAN; PIPERANOMETOZINE; PYRROLIDINE DITHIOCARBAMATE; SALICYLATE SODIUM; SUN C8079; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; DISEASE COURSE; DRUG EFFECT; DRUG MECHANISM; DRUG RESEARCH; DRUG SCREENING; ENDOTOXEMIA; HEART FAILURE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; PATHOGENESIS; PATHOPHYSIOLOGY; PROGNOSIS; PROTEIN FUNCTION; REVIEW; SIDE EFFECT; STRESS;

EID: 4644273786     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2004.029.07.854170     Document Type: Review

References (52)

1. Baeuerle, P.A., Henkel, T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994, 12: 141-79.
2. Dixit, V., Mak, T.W. NF-κB signaling: Many roads lead to Madrid. Cell 2002, 111: 615-9.
3. Siebenlist, U., Franzoso, G., Brown, K. Structure, regulation and function of NF-κB. Annu Rev Cell Biol 1994, 10: 405-55.
4. Baeuerle, P.A., Baltimore, D. NF-κB: Ten years after. Cell 1996, 87: 13-20.
5. Nunokawa, Y., Oikawa, S., Tanaka, S. Human inducible nitric oxide synthase gene is transcriptionally regulated by nuclear factor-κB dependent mechanism. Biochem Biophys Res Comm 1996, 223: 347-52.
6. Burkitt, M.J., Bishop, H.S., Milne, H.S. et al. Dithiocarbamate toxicity toward thymocytes involves their copper-catalyzed conversion to thiuram disulfides, which oxidize glutathione in a redox cycle without the release of reactive oxygen species. Arch Biochem Biophys 1998, 353: 73-84.
7. Saklatvala, J. Glucocorticoids: Do we know how they work? Arthritis Res 2002, 4: 146-50.
8. Chu, W.M., Ostertag, D., Li, Z.W. et al. JNK2 and IKKβ are required for activating the innate response to viral infection. Immunity 1999, 11: 721-31.
9. Harling-McNabb, L., Deliyannis, G., Jackson, D.C., Gerondakis, S., Grigoriadis, G., Brown, L.E. Mice lacking the transcription factor subunit ReI can clear an influenza infection and have functional anti-viral cytotoxic T cells but do not develop an optimal antibody response. Int Immunol 1999, 11: 1431-9.
10. Roulston, A., Marcellus, R.C., Branton, P.E. Viruses and apoptosis. Annu Rev Microbiol 1999, 53: 577-628.
11. Nabel, G., Baltimore, D. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 1987, 326: 711-3.
12. Rong, B.L., Libermann, T.A., Kogawa, K. et al. HSV-1-inducible proteins bind to NF-κB-like sites in the HSV-1 genome. Virology 1992, 189: 750-6.
13. Surabhi, R.M., Gaynor, R.B. RNA interference directed against viral and cellular targets inhibits human immunodeficiency virus type 1 replication. J Virol 2002, 76: 12963-73.
14. Matsumori, A. Molecular and immune mechanisms in the pathogenesis of cardiomyopathy. Role of viruses, cytokines, and nitric oxide. Jpn Circ J 1997, 61: 275-91.
15. Matsumori, A., Yamada, T., Suzuki, H., Matoba, Y., Sasayama, S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 1994, 72: 561-6.
16. Levine, B., Kaiman, J., Mayer, L., Fillit, H.M., Packer, M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. New Engl J Med 1990, 323: 236-41.
17. Gupta, S., Purcell, N.H., Lin, A., Sen, S. Activation of nuclear factor-κB is necessary for myotrophin-induced cardiac hypertrophy. J Cell Biol 2002, 159: 1019-28.
18. Hirotani, S., Otsu, K., Nishida, K. et al. Involvement of nuclear factor-κB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy. Circulation 2002, 105: 509-15.
19. Frantz, S., Fraccarollo, D., Wagner, H. et al. Sustained activation of nuclear factor κB and activator protein 1 in chronic heart failure. Cardiovasc Res 2003, 57: 749-56.
20. Yamada, T., Matsumori, A., Sasayama, S. Therapeutic effect of anti-tumor necrosis factor-α antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus. Circulation 1994, 89: 846-51.
21. Shioi, T., Matsumori, A., Sasayama, S. Persistent expression of cytokine in the chronic stage of viral myocarditis in mice. Circulation 1996, 94: 2930-7.
22. Wada, H., Saito, K., Kanda, T. et al. Tumor necrosis factor-α (TNF-α) plays a protective role in acute viral myocarditis in mice. A study using mice lacking TNF-α. Circulation 2001, 103: 743-9.
23. Iwasaki, A., Matsumori, A., Yamada, T. et al. Pimobendan inhibits the production of proinflammatory cytokines and gene expression of inducible nitric oxide synthase in a murine model of viral myocarditis. J Am Coll Cardiol 1999, 33: 1400-7.
24. The EPOCH Study Group. Effects of pimobendan on adverse cardiac events and physical activities in patients with mild to moderate chronic heart failure: The Effects of Pimobendan on Chronic Heart Failure study (EPOCH study). Circ J 2002, 66: 149-57.
25. Matsumori, A., Nunokawa, Y., Sasayama, S. Pimobendan inhibits the activation of transcription factor NF-κB: A mechanism which explains its inhibition of cytokine production and inducible nitric oxide synthase. Life Sci 2000, 67: 2513-9.
26. Chanani, N.K., Cowan, D.B., Takeuchi, K. et al. Differential effects ofamrinone and milrinone upon myocardial inflammatory signaling. Circulation 2002, 106 (Suppl. I): 1284-9.
27. Sha, W.C., Liou, H.C., Tuomanen, E.I., Baltimore, D. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 1995, 80: 321-30.
28. Matsumori, A., Nunokawa, Y., Yamaki, A. et al. Suppression of cytokines and nitric oxide production, and protection against lethal endotoxemia and viral myocarditis by a new NF-κB inhibitor. Eur J Heart Fail 2003, 6: 137-44.
29. Tomioka, N., Kishimoto, C., Matsumori, A., Kawai, C. Effects of prednisolone on acute viral myocarditis in mice. J Am Coll Cardiol 1986, 7: 868-72.
30. Monrad, E.S., Matsumori, A., Murphy, J.C., Fox, J.G., Crumpacker, C.S., Abelmann, W.H. Therapy with cyclosporine in experimental murine myocarditis with encephalomyocarditis virus. Circulation 1986, 73: 1058-64.
31. Nunokawa, Y., Ishida, N., Tanaka, S. Promoter analysis of human inducible nitric oxide synthase gene associated with cardiovascular homeostasis. Biochem Biophys Res Comm 1994, 200: 802-7.
32. Wang, W.-Z., Matsumori, A., Yamada, T. et al. Beneficial effects of amlodipine in a murine model of congestive heart failure induced by viral myocarditis: A possible mechanism through inhibition of nitric oxide production. Circulation 1997, 95: 245-51.
33. Matsumori, A. Assessment of Response to Candesartan in Heart Failure in Japan (ARCH-J) Study Investigators. Efficacy and safety of oral candersartan cilexetil in patients with congestive heart failure. Eur J Heart Fail 2003, 5: 669-77.
34. Suzuki, H., Matsumori, A., Matoba, Y. et al. Enhanced expression of Superoxide dismutase messenger RNA in viral myocarditis. An SH-dependent reduction of its expression and myocardial injury. J Clin Invest 1993, 91: 2727-33.
35. Tanaka, A., Matsumori, A., Wang, W., Sasayama, S. An angiotensin II receptor antagonist reduces myocardial damage in an animal model of myocarditis. Circulation 1994, 90: 2051-5.
36. 2 receptors. Am J Pathol 2001, 158: 1743-56.
37. Ruiz-Ortega, M., Lorenzo, O., Suzuki, Y., Ruperez, M., Egido, J. Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens 2001, 10: 321-9.
38. Schultz, J.J., Witt, S.A., Glascock, B.J. et al. TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. J Clin Invest 2002, 109: 787-96.
39. Yamamoto, K., Shioi, T., Uchiyama, K., Miyamoto, T., Sasayama, S., Matsumori, A. Attenuation of virus-induced myocardial injury by inhibition of the angiotensin II type 1 receptor signal and decreased nuclear factor-κB activation in knockout mice. J Am Coll Cardiol 2003, 42: 2000-6.
40. Sun, Y., Zhang, J., Lu, L., Chen, S.S., Quinn, M.T., Weber, K.T. Aldosterone-induced inflammation in the rat heart: Role of oxidative stress. Am J Pathol 2002, 161: 1773-81.
41. Matsumori, A. Anti-inflammatory therapy for heart failure. Curr Opin Pharmacol 2004, 4: 171-6.
42. Hoffman, A., Levchenko, A., Scott, M.L., Baltimore, D. The Iκ B-NF-κB signaling module: Temporal control and selective gene activation. Science 2002, 298: 1241-5.
43. Collins, T., Read, M.A., Neish, A.S., Whitley, M.Z., Thanos, D., Maniatis, T. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J 1995, 9: 899-909.
44. Antwerp, D.J.V., Martin, S.J., Kafri, T., Green, D.R., Verma, I.M. Suppression of TNF-α-induced apoptosts by NF-κB. Science 1996, 274: 787-9.
45. Xuan, Y.-T., Tang, X.-L., Banerjee, S. et al. Nuclear factor-κB plays an essential role in the late phase of ischemie preconditioning in conscious rabbits. Circ Res 1999, 84: 1095-109.
46. Valen, G., Van, Z.Q., Hansson, G.K. Nuclear factor κB and the heart. J Am Coll Cardiol 2001, 38: 307-14.
47. Kopp, E., Ghosh, S. Inhibition of NF-κB by sodium salicylate and aspirin. Science 1994, 265: 956-9.
48. Yang, J.P., Merin, J.P., Nakano, T., Kato, T., Kitade, Y, Okamoto, T. Inhibition of the DNA-binding activity of NF-κB by gold compounds in vitro. FEBS Lett 1995, 361: 89-96.
49. Liu, S.F., Ye, X., Malik, A.B. Inhibition of NF-κB activation by pyrrolidine dithiocarbamate prevents in vivo expression of proinflammatory genes. Circulation 1999, 100: 1330-7.
50. Lauzurica, P., Martinez-Martinez, S., Marazuela, M. et al. Pyrrolidine dithiocarbamate protects mice from lethal shock induced by LPS or TNF-α. Eur J Immunol 1999, 29: 1890-900.
51. Matsumori, A., Ono, K., Sato, Y, Shioi, T., Nose, Y., Sasayama, S. Differential modulation of cytokine production by drugs: Implication for therapy in heart failure. J Mol Cell Cardiol 1996, 28: 2491-9.
52. Matsumori, A., Okada, I., Shioi, T. et al. Inotropic agents differentially inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophage. Life Sci 1996, 59: PL121-5.